179 related articles for article (PubMed ID: 22947128)
1. Advantages of positron emission tomography-computed tomography imaging in esophageal squamous cell carcinoma.
Wang F; Shen LY; Ma SH; Li N; Yang Z; Chen KN
Dis Esophagus; 2013; 26(8):832-7. PubMed ID: 22947128
[TBL] [Abstract][Full Text] [Related]
2. Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography.
Roedl JB; Harisinghani MG; Colen RR; Fischman AJ; Blake MA; Mathisen DJ; Mueller PR
Ann Thorac Surg; 2008 Oct; 86(4):1131-8. PubMed ID: 18805147
[TBL] [Abstract][Full Text] [Related]
3. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma.
Yen TJ; Chung CS; Wu YW; Yen RF; Cheng MF; Lee JM; Hsu CH; Chang YL; Wang HP
Dis Esophagus; 2012 Jan; 25(1):40-7. PubMed ID: 21595776
[TBL] [Abstract][Full Text] [Related]
4. Detection of synchronous cancers by fluorodeoxyglucose positron emission tomography/computed tomography during primary staging workup for esophageal squamous cell carcinoma in Taiwan.
Chen SH; Chan SC; Chao YK; Yen TC
PLoS One; 2013; 8(11):e82812. PubMed ID: 24312435
[TBL] [Abstract][Full Text] [Related]
5. Patterns of nodal metastases on 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma are useful to guide treatment planning of radiotherapy.
Liu CJ; Cheng JC; Lee JM; Cheng MF; Tzen KY; Yen RF
Clin Nucl Med; 2015 May; 40(5):384-9. PubMed ID: 25674870
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S
Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
[TBL] [Abstract][Full Text] [Related]
7. 18F-deoxyglucose positron emission tomography/computed tomography to predict local failure in esophageal squamous cell carcinoma.
Fan B; Fan P; Kong L; Sun X; Zhao S; Sun X; Fu Z; Zheng J; Ma L; Wang S; Hu M; Yu J
Oncotarget; 2017 May; 8(21):34498-34506. PubMed ID: 28404900
[TBL] [Abstract][Full Text] [Related]
8. The impact of ¹⁸F-fluorodeoxyglucose positron emission tomography positive lymph nodes on postoperative recurrence and survival in resectable thoracic esophageal squamous cell carcinoma.
Yasuda T; Higuchi I; Yano M; Miyata H; Yamasaki M; Takiguchi S; Fujiwara Y; Hatazawa J; Doki Y
Ann Surg Oncol; 2012 Feb; 19(2):652-60. PubMed ID: 21769466
[TBL] [Abstract][Full Text] [Related]
9. External ultrasonography of the neck does not add diagnostic value to integrated positron emission tomography-computed tomography (PET-CT) scanning in the diagnosis of cervical lymph node metastases in patients with esophageal carcinoma.
Blom RL; Vliegen RF; Schreurs WM; Belgers HJ; Stohr I; Oostenbrug LE; Sosef MN
Dis Esophagus; 2012 Aug; 25(6):555-9. PubMed ID: 22150869
[TBL] [Abstract][Full Text] [Related]
10. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794
[TBL] [Abstract][Full Text] [Related]
11. Relationship Between the Size of Metastatic Lymph Nodes and Positron Emission Tomographic/Computer Tomographic Findings in Patients with Esophageal Squamous Cell Carcinoma.
Park SY; Kim DJ; Jung HS; Yun MJ; Lee JW; Park CK
World J Surg; 2015 Dec; 39(12):2948-54. PubMed ID: 26324159
[TBL] [Abstract][Full Text] [Related]
12. The Role of Maximum Standardized Uptake Value in PET/CT as a Prognostic Factor in Patients with Resected Esophageal Squamous Cell Carcinoma.
Song IH; Cho S; Yang HC; Jheon S
Thorac Cardiovasc Surg; 2015 Jun; 63(4):335-40. PubMed ID: 25068775
[TBL] [Abstract][Full Text] [Related]
13. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
[TBL] [Abstract][Full Text] [Related]
14. [Impact of (18)F-FDG PET/CT on the therapeutic management in the initial staging of the esophageal cancer].
Pifarré-Montaner P; Fernández-León A; de Juan R; del Ama-Salvador ME; Galán M; Gámez-Cenzano C; Sans M
Rev Esp Med Nucl; 2009; 28(3):101-5. PubMed ID: 19558949
[TBL] [Abstract][Full Text] [Related]
15. Tumor/normal esophagus ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for response and prognosis stratification after neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
Izumi D; Yoshida N; Watanabe M; Shiraishi S; Ishimoto T; Kosumi K; Tokunaga R; Taki K; Higashi T; Harada K; Miyata T; Ida S; Imamura Y; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yamashita Y; Baba H
J Gastroenterol; 2016 Aug; 51(8):788-95. PubMed ID: 26671045
[TBL] [Abstract][Full Text] [Related]
16. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
[TBL] [Abstract][Full Text] [Related]
17. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A
Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Computerized Tomography (PET-CT) Scan in Identifying Interval Metastases for Patients with Esophageal Cancer.
Gabriel E; Alnaji R; Du W; Attwood K; Kukar M; Hochwald S
Ann Surg Oncol; 2017 Jun; 24(6):1739-1746. PubMed ID: 28058562
[TBL] [Abstract][Full Text] [Related]
19. Use of (18)F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma.
Makino T; Doki Y; Miyata H; Yasuda T; Yamasaki M; Fujiwara Y; Takiguchi S; Higuchi I; Hatazawa J; Monden M
Surgery; 2008 Nov; 144(5):793-802. PubMed ID: 19081023
[TBL] [Abstract][Full Text] [Related]
20. Positron-Emission Tomography Scan-Directed Chemoradiation for Esophageal Squamous Cell Carcinoma: No Benefit for a Change in Chemotherapy in Positron-Emission Tomography Nonresponders.
Greally M; Chou JF; Molena D; Rusch VW; Bains MS; Park BJ; Wu AJ; Goodman KA; Kelsen DP; Janjigian YY; Ilson DH; Ku GY
J Thorac Oncol; 2019 Mar; 14(3):540-546. PubMed ID: 30391577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
